The 2013 BBK Worldwide conference tour kicks off in February with the 4th Annual Summit for Clinical Ops Executives (SCOPE). A few months ago we interviewed Micah Liberman, Executive Director of SCOPE about his insights from the conference. You can find that interview here. Micah explained in his interview how, “It’s a challenging time in clinical research and it’s also an opportune time in this area. Now more than ever, you cannot go at it alone and you need to think way outside of your own box/group.”
For those of you who don’t know, I’m a little obsessed with social media. Some might even say I have a problem. So when BBK was gearing up for the Disruptive Innovation and Global Clinical Trials Conference last September, which was put on by The Conference Forum, I scoured the social media world for information about the conference, who was going, groups I could join etc. Every group I found and joined or page I followed, I always found postings from Valerie Bowling. I wondered, “Is she as obsessed with social media as I am?” Either way I had to talk to her. So here’s my conversation with Valerie Bowling about The Conference Forum and their goals for creating great conferences for the pharmaceutical and patient recruitment industry to attend.
Last week, the Allan Lloyds Group brought to Chicago the very successful Patient Recruitment and Retention Summit - USA. This summit is an excellent occasion for business, with presentations on interesting case studies and ample opportunities for knowledge sharing. An exceptional group of clinical development professionals were generous in sharing their experiences, insights, and ways in which they are pushing the envelope to engage patients in clinical studies.
If you haven’t figured out already, BBK looooooooves metrics. It’s something we often talk about in our blog (Real-Time Enrollment Data, Right Now). Oh and let’s not forget, the development of our patient recruitment management system, TrialCentralNet(SM). That all being said, we are excited to continue our campaign for the importance of metrics. Next stop? Allan Lloyd’s Patient Recruitment and Retention Summit in Chicago, October 23rd-25th.
I first met Micah Lieberman, Executive Director of conferences at the Cambridge Healthtech Institute, at last year’s Summit for Clinical Ops Executives (SCOPE) while watching the New England Patriots and New York Giants in Superbowl XLVI. After the Patriots lost, I was devastated. It’s still hard for me to discuss now without wanting to rip my hair out. Anyway, Micah picked me up off the ground and reminded me that I needed to prepare myself for one of the greatest conferences of the year and that I had to put my game face on and be ready to go! Somehow, someway, Micah’s words got to me and the next morning, after several cups of coffee, I was ready. So in honor of that night and Micah’s inspirational words, we decided to sit down and talk about SCOPE and the value it has to the patient recruitment industry.
The BBK Worldwide conference tour continues when The Conference Forum hosts its' third annual “Executing Global Clinical Trials Conference” in Boston from the 13th-14th of September. We are excited to be a sponsor of this event and look forward to meeting new people in the patient recruitment industry and reconnecting with some familiar faces. During the conference, BBK executives will take the lead in two speaking engagements during the event. Matt Kibby will moderate a panel discussion exploring global research on rare conditions. Then, Bonnie A. Brescia will present a case study on social media and other novel approaches in international clinical trials.
The 2012 DIA was amazing! It’s no secret that our t-shirts were a big hit! We brought about 1,500 t-shirts with us and half way through the second day, we were all out. As our co-founder Joan Bachenheimer said and wrote about, “You gotta have a gimmick if you want to get a chance.” Our t-shirts certainly did just that. While we were busy with our “gimmick,” there were other important meetings and conversations we had. So, team BBK DIA has decided to share some of those insights with you below.